PHIO
Price
$3.00
Change
+$0.54 (+21.95%)
Updated
Jun 6, 12:31 PM (EDT)
Capitalization
11.8M
QLGN
Price
$3.74
Change
-$0.07 (-1.84%)
Updated
Jun 6, 11:43 AM (EDT)
Capitalization
2.81M
Interact to see
Advertisement

PHIO vs QLGN

Header iconPHIO vs QLGN Comparison
Open Charts PHIO vs QLGNBanner chart's image
Phio Pharmaceuticals
Price$3.00
Change+$0.54 (+21.95%)
Volume$2.17K
Capitalization11.8M
Qualigen Therapeutics
Price$3.74
Change-$0.07 (-1.84%)
Volume$100
Capitalization2.81M
PHIO vs QLGN Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHIO vs. QLGN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Buy and QLGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (PHIO: $2.46 vs. QLGN: $3.81)
Brand notoriety: PHIO and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 155% vs. QLGN: 5%
Market capitalization -- PHIO: $11.8M vs. QLGN: $2.81M
PHIO [@Biotechnology] is valued at $11.8M. QLGN’s [@Biotechnology] market capitalization is $2.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 1 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 1 green, 4 red.
According to our system of comparison, QLGN is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 4 TA indicator(s) are bullish while QLGN’s TA Score has 3 bullish TA indicator(s).

  • PHIO’s TA Score: 4 bullish, 4 bearish.
  • QLGN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both PHIO and QLGN are a good buy in the short-term.

Price Growth

PHIO (@Biotechnology) experienced а +20.59% price change this week, while QLGN (@Biotechnology) price change was +0.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.55%. For the same industry, the average monthly price growth was +17.24%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

PHIO is expected to report earnings on Mar 31, 2025.

QLGN is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (+11.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($11.8M) has a higher market cap than QLGN($2.81M). PHIO has higher P/E ratio than QLGN: PHIO (0.01) vs QLGN (0.00). PHIO YTD gains are higher at: 36.667 vs. QLGN (-9.501). QLGN has higher annual earnings (EBITDA): -6.73M vs. PHIO (-7.41M). PHIO has more cash in the bank: 5.39M vs. QLGN (388K). PHIO has less debt than QLGN: PHIO (0) vs QLGN (1.43M). PHIO (0) and QLGN (0) have equivalent revenues.
PHIOQLGNPHIO / QLGN
Capitalization11.8M2.81M421%
EBITDA-7.41M-6.73M110%
Gain YTD36.667-9.501-386%
P/E Ratio0.010.001,161%
Revenue00-
Total Cash5.39M388K1,389%
Total Debt01.43M-
FUNDAMENTALS RATINGS
PHIO vs QLGN: Fundamental Ratings
PHIO
QLGN
OUTLOOK RATING
1..100
2917
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4958
P/E GROWTH RATING
1..100
6646
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (27) in the null industry is in the same range as PHIO (58) in the Biotechnology industry. This means that QLGN’s stock grew similarly to PHIO’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as PHIO (100) in the Biotechnology industry. This means that QLGN’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's SMR Rating (96) in the Biotechnology industry is in the same range as QLGN (100) in the null industry. This means that PHIO’s stock grew similarly to QLGN’s over the last 12 months.

PHIO's Price Growth Rating (49) in the Biotechnology industry is in the same range as QLGN (58) in the null industry. This means that PHIO’s stock grew similarly to QLGN’s over the last 12 months.

QLGN's P/E Growth Rating (46) in the null industry is in the same range as PHIO (66) in the Biotechnology industry. This means that QLGN’s stock grew similarly to PHIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIOQLGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SANA2.550.23
+9.70%
Sana Biotechnology
MP25.931.35
+5.49%
MP Materials Corp
TRX0.350.01
+2.76%
TRX Gold Corp
APA17.85-0.07
-0.39%
APA Corp
GWAV0.20-0.02
-9.32%
Greenwave Technology Solutions Inc.